Chairman's Message
Dear Stakeholders,
I take the pleasure of presenting you with our Sustainability Report 2009. A quarter of a century has evolved before us, as we have steadily treaded the path of sustainability, with the purpose of providing affordable and innovative medicines to all. For Dr. Reddy’s, Sustainability goes beyond our conscious attempt to conserve resources and build sustainable relationships with our business partners; it is also a vital area of cost savings, revenue generation and competitive advantage. Along the journey as we gained fresh perspectives, we have re-energized our goals, advancing our commitment to the stakeholder community that supports us by investing in sustainability through collective actions.
I would like to stress on what we have done in social change, community development and discovery research. Our engagement with the larger community continues through various programs conducted by DRF on the crucial issues of Education and Livelihoods. Addressing the vital link between education and vocational / livelihood based skills, DRF Livelihood Advancement Business School (LABS) as on July 2009, has provided livelihood opportunities for over 190,000 youth.
We also take pride in the English-medium education to children through four Pudami Neighbourhood Schools in Hyderabad and Ranga Reddy districts. The ‘Ensuring Children Learn’ program has reached out to over 16,000 children in 378 schools. Engaging with the Naandi Foundation, a well-recognised social sector organization, our employees contribute under the Power of 10 employee giving program towards health and education programs, as well as safe motherhood and child healthcare initiatives.
As part of our stakeholder engagement, focus group interviews were conducted among employees, to gauge their awareness levels and get their suggestions on our Sustainability initiatives. Employees felt proud of their involvement in the employee giving program ‘Power of 10’ as it was a direct, personal contribution towards Sustainability. We will continue to strengthen community engagement through a wide variety of initiatives and also respond to employee feedback regarding volunteering. I’ll say a few more words on the progress of the Naandi’s WaterHealth project. Andhra Pradesh has 350 plants which has encouraged us to approach other states in the country. Naandi’s Giddarbah pilot in 2007 set up 60 plants in 90 days making it the first constituency in India where every household has access to drinking water as per WHO norms at a minimal cost of Rs.1 for 10 litres of water. Today, Punjab and Haryana have 300 and 50 water plants respectively. Naandi has also set up 20 plants in Rajasthan with another 20 plants planned in Karnataka.
Fifteen years ago, we were the first in the Indian pharmaceutical space to embark on the high–risk, capital intensive journey of discovering new drugs (NCE). We built well equipped labs and put together a team of highly skilled scientists. Over the years our company kept its faith in drug discovery and at the same time has believed in keeping in tune with the interests of all its stakeholders. Accordingly, we have recently announced the restructuring of our R&D operations. We will now be placing utmost emphasis on R&D activities that can have a significant impact on near-term earnings, while not losing focus on long-term interests of the company. Effective 1st June 2009 , the Drug Discovery operations in Hyderabad (Discovery Research for us) has merged with Aurigene, our wholly owned Drug Discovery subsidiary in Bangalore. A new group called the Proprietary Products group will build the proprietary, branded R&D portfolio for the company in collaboration with various partners and other biotechs. This group will be responsible for the existing IP of the company and will ensure effective management of ongoing and future drug discovery programs.
As winter approaches, I watch the birds flying south to be on their momentous journey in search of plentiful food, in the cold months. They fly in a fascinating V formation and as I recall the Goose story, I find there is a lesson hidden in it for us all:
Giving back to the community that supports us is a mission at Dr. Reddy’s that we have been implementing from our earliest days. Over time, our efforts were stepped up to build long-term value for individuals and society as a whole. Today, we reinstate our steadfastness towards sustainable development with collective action along with our employees, our strategic business partners, involving government and multilateral organizations, social institutions, universities and academia, industry, in particular the pharma and biotech sectors. From this vantage point we look ahead to another silver jubilee of milestones in sustainable business partnership in the global pharma arena.
Dr. K.Anji Reddy
I take the pleasure of presenting you with our Sustainability Report 2009. A quarter of a century has evolved before us, as we have steadily treaded the path of sustainability, with the purpose of providing affordable and innovative medicines to all. For Dr. Reddy’s, Sustainability goes beyond our conscious attempt to conserve resources and build sustainable relationships with our business partners; it is also a vital area of cost savings, revenue generation and competitive advantage. Along the journey as we gained fresh perspectives, we have re-energized our goals, advancing our commitment to the stakeholder community that supports us by investing in sustainability through collective actions.
I would like to stress on what we have done in social change, community development and discovery research. Our engagement with the larger community continues through various programs conducted by DRF on the crucial issues of Education and Livelihoods. Addressing the vital link between education and vocational / livelihood based skills, DRF Livelihood Advancement Business School (LABS) as on July 2009, has provided livelihood opportunities for over 190,000 youth.
We also take pride in the English-medium education to children through four Pudami Neighbourhood Schools in Hyderabad and Ranga Reddy districts. The ‘Ensuring Children Learn’ program has reached out to over 16,000 children in 378 schools. Engaging with the Naandi Foundation, a well-recognised social sector organization, our employees contribute under the Power of 10 employee giving program towards health and education programs, as well as safe motherhood and child healthcare initiatives.
As part of our stakeholder engagement, focus group interviews were conducted among employees, to gauge their awareness levels and get their suggestions on our Sustainability initiatives. Employees felt proud of their involvement in the employee giving program ‘Power of 10’ as it was a direct, personal contribution towards Sustainability. We will continue to strengthen community engagement through a wide variety of initiatives and also respond to employee feedback regarding volunteering. I’ll say a few more words on the progress of the Naandi’s WaterHealth project. Andhra Pradesh has 350 plants which has encouraged us to approach other states in the country. Naandi’s Giddarbah pilot in 2007 set up 60 plants in 90 days making it the first constituency in India where every household has access to drinking water as per WHO norms at a minimal cost of Rs.1 for 10 litres of water. Today, Punjab and Haryana have 300 and 50 water plants respectively. Naandi has also set up 20 plants in Rajasthan with another 20 plants planned in Karnataka.
Fifteen years ago, we were the first in the Indian pharmaceutical space to embark on the high–risk, capital intensive journey of discovering new drugs (NCE). We built well equipped labs and put together a team of highly skilled scientists. Over the years our company kept its faith in drug discovery and at the same time has believed in keeping in tune with the interests of all its stakeholders. Accordingly, we have recently announced the restructuring of our R&D operations. We will now be placing utmost emphasis on R&D activities that can have a significant impact on near-term earnings, while not losing focus on long-term interests of the company. Effective 1st June 2009 , the Drug Discovery operations in Hyderabad (Discovery Research for us) has merged with Aurigene, our wholly owned Drug Discovery subsidiary in Bangalore. A new group called the Proprietary Products group will build the proprietary, branded R&D portfolio for the company in collaboration with various partners and other biotechs. This group will be responsible for the existing IP of the company and will ensure effective management of ongoing and future drug discovery programs.
As winter approaches, I watch the birds flying south to be on their momentous journey in search of plentiful food, in the cold months. They fly in a fascinating V formation and as I recall the Goose story, I find there is a lesson hidden in it for us all:
Next
time, when
you see Geese
heading South for
the Winter, flying along
in V formation, you might
consider what science has dis-
covered as to why they fly that way:
as each bird flaps its wings, it creates an
uplift for the bird immediately following. By
flying in V formation the whole flock adds at least
71% greater flying range than if each bird flew on its own.
People who share a common direction and sense of community
can get where they are going more quickly and easily
because they are traveling on the thrust of one another.*
time, when
you see Geese
heading South for
the Winter, flying along
in V formation, you might
consider what science has dis-
covered as to why they fly that way:
as each bird flaps its wings, it creates an
uplift for the bird immediately following. By
flying in V formation the whole flock adds at least
71% greater flying range than if each bird flew on its own.
People who share a common direction and sense of community
can get where they are going more quickly and easily
because they are traveling on the thrust of one another.*
Giving back to the community that supports us is a mission at Dr. Reddy’s that we have been implementing from our earliest days. Over time, our efforts were stepped up to build long-term value for individuals and society as a whole. Today, we reinstate our steadfastness towards sustainable development with collective action along with our employees, our strategic business partners, involving government and multilateral organizations, social institutions, universities and academia, industry, in particular the pharma and biotech sectors. From this vantage point we look ahead to another silver jubilee of milestones in sustainable business partnership in the global pharma arena.
Dr. K.Anji Reddy
Font Size
© 2001 - 2009 Dr. Reddy's Laboratories Ltd.
Best viewed in 1024x780 resolution